Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia

Iván Chavarría-Siles, Javier Contreras-Rojas, Elizabeth Hare, Consuelo Walss-Bass, Paulina Quezada, Albana M Dassori, Salvador Contreras, Rolando Medina, Mercedes Ramírez, Rodolfo Salazar, Henriette Raventos, Michael A. Escamilla

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Functional alterations of components of the endogenous cannabinoid system, in particular of the cannabinoid receptor 1 protein (CB1), are hypothetical contributors to many of the symptoms seen in schizophrenia. Variants within the cannabinoid receptor 1 gene (CNR1) have been shown to be directly associated with the hebephrenic form of schizophrenia in a Japanese population. This finding, however, has yet to be replicated. In the present study we sought to study the same (AAT)n-repeat microsatellite of the CNR1 gene which showed association to hebephrenic schizophrenia in Japan, and to investigate whether this microsatellite showed association to a hebephrenic type of schizophrenia in a family-based association study in a population of the Central Valley of Costa Rica. The Lifetime Dimensions of Psychosis Scale and a best estimate consensus process were utilized to identify subjects with schizophrenia who had an elevated lifetime dimensional score for negative and disorganized symptoms, which we used as a proxy for "hebephrenia." Using the Family Based Association Test we found association of these hebephrenic subjects and the (AAT)n-repeat marker of the CNR1 (multi-allelic P = 0.0368). Our hypothesis that an association with the (AAT)n-repeat marker of CNR1 would not be found with the more general type of schizophrenia was also confirmed. Schizophrenic subjects with prominent lifetime scores for disorganization and negative symptoms (dimension for hebephrenia) are associated with the CNR1 gene and present a type of symptomatology that resembles chronic cannabinoid-induced psychosis. The current finding points to the possibility of different genetic and pathophysiologic mechanisms underlying different types of schizophrenia.

Original languageEnglish (US)
Pages (from-to)279-284
Number of pages6
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Volume147
Issue number3
DOIs
StatePublished - Apr 5 2008

Fingerprint

Disorganized Schizophrenia
Cannabinoid Receptors
Phenotype
Schizophrenia
Genes
Cannabinoids
Psychotic Disorders
Microsatellite Repeats
Costa Rica
Proxy
Population
Consensus
Japan

Keywords

  • Central Valley of Costa Rica
  • CNR1
  • Disorganization
  • Hebephrenic schizophrenia
  • Negative symptoms

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

Chavarría-Siles, I., Contreras-Rojas, J., Hare, E., Walss-Bass, C., Quezada, P., Dassori, A. M., ... Escamilla, M. A. (2008). Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 147(3), 279-284. https://doi.org/10.1002/ajmg.b.30592

Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. / Chavarría-Siles, Iván; Contreras-Rojas, Javier; Hare, Elizabeth; Walss-Bass, Consuelo; Quezada, Paulina; Dassori, Albana M; Contreras, Salvador; Medina, Rolando; Ramírez, Mercedes; Salazar, Rodolfo; Raventos, Henriette; Escamilla, Michael A.

In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 147, No. 3, 05.04.2008, p. 279-284.

Research output: Contribution to journalArticle

Chavarría-Siles, I, Contreras-Rojas, J, Hare, E, Walss-Bass, C, Quezada, P, Dassori, AM, Contreras, S, Medina, R, Ramírez, M, Salazar, R, Raventos, H & Escamilla, MA 2008, 'Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 147, no. 3, pp. 279-284. https://doi.org/10.1002/ajmg.b.30592
Chavarría-Siles, Iván ; Contreras-Rojas, Javier ; Hare, Elizabeth ; Walss-Bass, Consuelo ; Quezada, Paulina ; Dassori, Albana M ; Contreras, Salvador ; Medina, Rolando ; Ramírez, Mercedes ; Salazar, Rodolfo ; Raventos, Henriette ; Escamilla, Michael A. / Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. In: American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 2008 ; Vol. 147, No. 3. pp. 279-284.
@article{9b80821fe7034da38a52bc53854fc0d5,
title = "Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia",
abstract = "Functional alterations of components of the endogenous cannabinoid system, in particular of the cannabinoid receptor 1 protein (CB1), are hypothetical contributors to many of the symptoms seen in schizophrenia. Variants within the cannabinoid receptor 1 gene (CNR1) have been shown to be directly associated with the hebephrenic form of schizophrenia in a Japanese population. This finding, however, has yet to be replicated. In the present study we sought to study the same (AAT)n-repeat microsatellite of the CNR1 gene which showed association to hebephrenic schizophrenia in Japan, and to investigate whether this microsatellite showed association to a hebephrenic type of schizophrenia in a family-based association study in a population of the Central Valley of Costa Rica. The Lifetime Dimensions of Psychosis Scale and a best estimate consensus process were utilized to identify subjects with schizophrenia who had an elevated lifetime dimensional score for negative and disorganized symptoms, which we used as a proxy for {"}hebephrenia.{"} Using the Family Based Association Test we found association of these hebephrenic subjects and the (AAT)n-repeat marker of the CNR1 (multi-allelic P = 0.0368). Our hypothesis that an association with the (AAT)n-repeat marker of CNR1 would not be found with the more general type of schizophrenia was also confirmed. Schizophrenic subjects with prominent lifetime scores for disorganization and negative symptoms (dimension for hebephrenia) are associated with the CNR1 gene and present a type of symptomatology that resembles chronic cannabinoid-induced psychosis. The current finding points to the possibility of different genetic and pathophysiologic mechanisms underlying different types of schizophrenia.",
keywords = "Central Valley of Costa Rica, CNR1, Disorganization, Hebephrenic schizophrenia, Negative symptoms",
author = "Iv{\'a}n Chavarr{\'i}a-Siles and Javier Contreras-Rojas and Elizabeth Hare and Consuelo Walss-Bass and Paulina Quezada and Dassori, {Albana M} and Salvador Contreras and Rolando Medina and Mercedes Ram{\'i}rez and Rodolfo Salazar and Henriette Raventos and Escamilla, {Michael A.}",
year = "2008",
month = "4",
day = "5",
doi = "10.1002/ajmg.b.30592",
language = "English (US)",
volume = "147",
pages = "279--284",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia

AU - Chavarría-Siles, Iván

AU - Contreras-Rojas, Javier

AU - Hare, Elizabeth

AU - Walss-Bass, Consuelo

AU - Quezada, Paulina

AU - Dassori, Albana M

AU - Contreras, Salvador

AU - Medina, Rolando

AU - Ramírez, Mercedes

AU - Salazar, Rodolfo

AU - Raventos, Henriette

AU - Escamilla, Michael A.

PY - 2008/4/5

Y1 - 2008/4/5

N2 - Functional alterations of components of the endogenous cannabinoid system, in particular of the cannabinoid receptor 1 protein (CB1), are hypothetical contributors to many of the symptoms seen in schizophrenia. Variants within the cannabinoid receptor 1 gene (CNR1) have been shown to be directly associated with the hebephrenic form of schizophrenia in a Japanese population. This finding, however, has yet to be replicated. In the present study we sought to study the same (AAT)n-repeat microsatellite of the CNR1 gene which showed association to hebephrenic schizophrenia in Japan, and to investigate whether this microsatellite showed association to a hebephrenic type of schizophrenia in a family-based association study in a population of the Central Valley of Costa Rica. The Lifetime Dimensions of Psychosis Scale and a best estimate consensus process were utilized to identify subjects with schizophrenia who had an elevated lifetime dimensional score for negative and disorganized symptoms, which we used as a proxy for "hebephrenia." Using the Family Based Association Test we found association of these hebephrenic subjects and the (AAT)n-repeat marker of the CNR1 (multi-allelic P = 0.0368). Our hypothesis that an association with the (AAT)n-repeat marker of CNR1 would not be found with the more general type of schizophrenia was also confirmed. Schizophrenic subjects with prominent lifetime scores for disorganization and negative symptoms (dimension for hebephrenia) are associated with the CNR1 gene and present a type of symptomatology that resembles chronic cannabinoid-induced psychosis. The current finding points to the possibility of different genetic and pathophysiologic mechanisms underlying different types of schizophrenia.

AB - Functional alterations of components of the endogenous cannabinoid system, in particular of the cannabinoid receptor 1 protein (CB1), are hypothetical contributors to many of the symptoms seen in schizophrenia. Variants within the cannabinoid receptor 1 gene (CNR1) have been shown to be directly associated with the hebephrenic form of schizophrenia in a Japanese population. This finding, however, has yet to be replicated. In the present study we sought to study the same (AAT)n-repeat microsatellite of the CNR1 gene which showed association to hebephrenic schizophrenia in Japan, and to investigate whether this microsatellite showed association to a hebephrenic type of schizophrenia in a family-based association study in a population of the Central Valley of Costa Rica. The Lifetime Dimensions of Psychosis Scale and a best estimate consensus process were utilized to identify subjects with schizophrenia who had an elevated lifetime dimensional score for negative and disorganized symptoms, which we used as a proxy for "hebephrenia." Using the Family Based Association Test we found association of these hebephrenic subjects and the (AAT)n-repeat marker of the CNR1 (multi-allelic P = 0.0368). Our hypothesis that an association with the (AAT)n-repeat marker of CNR1 would not be found with the more general type of schizophrenia was also confirmed. Schizophrenic subjects with prominent lifetime scores for disorganization and negative symptoms (dimension for hebephrenia) are associated with the CNR1 gene and present a type of symptomatology that resembles chronic cannabinoid-induced psychosis. The current finding points to the possibility of different genetic and pathophysiologic mechanisms underlying different types of schizophrenia.

KW - Central Valley of Costa Rica

KW - CNR1

KW - Disorganization

KW - Hebephrenic schizophrenia

KW - Negative symptoms

UR - http://www.scopus.com/inward/record.url?scp=42149110869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149110869&partnerID=8YFLogxK

U2 - 10.1002/ajmg.b.30592

DO - 10.1002/ajmg.b.30592

M3 - Article

C2 - 18186055

AN - SCOPUS:42149110869

VL - 147

SP - 279

EP - 284

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 3

ER -